Luis H Ocampo, MD
Internal Medicine · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Hospitals listed: Kaiser Foundation Hospital-San Jose. That is not proof they admit you there this week.
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Ocampo’s office at (408) 972-3000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
California Medical Board record
Licence A121409 · Current
Licensed to practise in California · since 2012 · expires 2028-05-31 · Meharry Medical College School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Kaiser Foundation Hospital-San JoseSan Jose, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Kaiser Permanente, which runs 41 hospitals in 3 statesPatients rate it 3 of 5 · 66% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.258, Oct 2024 – Sep 2025
See every measure and the patient survey for Kaiser Foundation Hospital-San Jose
Behind the star rating — Deaths: 0 better, 3 the same, 0 worse of 3 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 2 the same, 0 worse of 2 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.258 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.3 (0.22 to 2.37) · 181 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.89 (0.43 to 1.34) | No different | Jul 2022 – Jun 2024 |
| Death rate for pneumonia patientsComplications and deaths | 14.2 · 27 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.6 · 271 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 2,952 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.27 (0.04 to 0.5) · 894 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.48) · 908 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.19 (0.67 to 5.72) · 176 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.63 (0 to 3.34) · 61 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.23 (0.53 to 3.92) · 168 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.11 (0 to 17.58) · 68 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.85 (0.67 to 9.03) · 63 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.74 (0.22 to 3.26) · 51 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.43 (0 to 1.53) · 630 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 48 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.843 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.88 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.611 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15 · 171 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.9 · 571 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 147.1 · 28 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 21 · 639 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.6 · 48 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 157 cases | None | Jul 2023 – Jun 2025 |
What patients said (1,294 patients answered, 21% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 70% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 61% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 66% |
| Nurses "always" treated them with courtesy and respect | 78% |
| "Always" quiet at night | 37% |
| "YES", patients would definitely recommend the hospital | 66% |
| Staff "always" explained possible side effects | 41% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
Original Medicare doctor bills
$7,259
Medicare paid this office $7,259 for 12 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Procedures Medicare counted
| Colonoscopy | 1-10 | None |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 14 | More than 46% of doctors who do this |
Who their Medicare patients are
12 Original Medicare patients in 2024. Average age 68 · Health risk score 1.83. Above the middle of the specialty; the typical internal medicine clinician is at 1.76.
The office billed $103,744, Medicare allowed $9,623 and paid $7,259; for 269 services of 14 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 12 | 269 | 68 | 1.83 | $103,744 | $7,259 |
| 2023 | 15 | 22 | 64 | 2.36 | $16,788 | $4,050 |
| 2018 | 11 | 21 | 62 | 4.17 | $16,809 | $2,463 |
| 2017 | 12 | 23 | 67 | 1.95 | $17,563 | $2,700 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
Drugs they prescribed that Part D paid
$624,775
Pharmacies billed $624,775 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 678) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
562 generic and 116 brand-name prescriptions · $624,775 in drug cost · 32 antibiotic prescriptions to 12 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Stelara | 19 | $447,419 | $23,548 |
| Xifaxan | 16 | $52,120 | $3,257 |
| Creon | 15 | $25,081 | $1,672 |
| Motegrity | 13 | $13,279 | $1,021 |
| Mesalamine | 21 | $6,597 | $314 |
See all 14 drugs
| Stelara | 19 | $447,419 | $23,548 |
| Xifaxan | 16 | $52,120 | $3,257 |
| Creon | 15 | $25,081 | $1,672 |
| Motegrity | 13 | $13,279 | $1,021 |
| Mesalamine | 21 | $6,597 | $314 |
| Gavilyte-C | 225 | $5,035 | $22 |
| Lactulose | 38 | $1,599 | $42 |
| Omeprazole | 112 | $1,393 | $12 |
| Entecavir | 13 | $402 | $31 |
| Peg-3350 and Electrolytes | 15 | $385 | $26 |
| Famotidine | 26 | $340 | $13 |
| Pantoprazole | 16 | $214 | $13 |
| Carvedilol | 14 | $131 | $9 |
| Prednisone | 11 | $128 | $12 |
Year by year
| 2024 | 678 | 324 | 0% (0) | 17% | $624,775 |
| 2023 | 653 | 359 | 0% (0) | None | $366,603 |
| 2022 | 524 | 288 | 0% (0) | 28% | $188,837 |
| 2021 | 497 | 267 | 0% (0) | 22% | $152,149 |
| 2020 | 334 | 159 | 0% (0) | 18% | $64,578 |
| 2019 | 470 | 261 | 0% (0) | None | $121,035 |
| 2018 | 467 | 272 | 0% (0) | 37% | $73,949 |
| 2017 | 366 | 232 | 0% (0) | None | $54,432 |
| 2016 | 86 | 61 | 0% (0) | 22% | $5,151 |
| 2015 | 12 | None | None | None | $2,887 |
| 2014 | 52 | 51 | 0% (0) | 67% | $637 |
| 2013 | 112 | 42 | None | 29% | $4,776 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 12 drugs
| Stelara | 11 | $237,348 | $21,577 |
| Xifaxan | 11 | $39,804 | $3,619 |
| Creon | 19 | $17,290 | $910 |
| Gavilyte-C | 229 | $4,816 | $21 |
| Peg-3350 and Electrolytes | 52 | $1,314 | $25 |
| Budesonide Dr | 14 | $1,090 | $78 |
| Omeprazole | 70 | $838 | $12 |
| Lactulose | 24 | $835 | $35 |
| Entecavir | 11 | $813 | $74 |
| Famotidine | 29 | $487 | $17 |
| Pantoprazole | 20 | $220 | $11 |
| Furosemide | 11 | $128 | $12 |
2022: 10 drugs
| Creon | 12 | $10,880 | $907 |
| Lialda | 12 | $5,303 | $442 |
| Gavilyte-C | 154 | $2,674 | $17 |
| Peg-3350 and Electrolytes | 54 | $1,135 | $21 |
| Entecavir | 12 | $707 | $59 |
| Lactulose | 14 | $592 | $42 |
| Famotidine | 32 | $492 | $15 |
| Omeprazole | 44 | $427 | $10 |
| Spironolactone | 11 | $223 | $20 |
| Pantoprazole | 13 | $167 | $13 |
2021: 9 drugs
| Xifaxan | 11 | $33,455 | $3,041 |
| Lialda | 18 | $9,638 | $535 |
| Peg-3350 and Electrolytes | 100 | $2,044 | $20 |
| Budesonide Ec | 13 | $1,423 | $109 |
| Gavilyte-C | 83 | $1,255 | $15 |
| Omeprazole | 44 | $616 | $14 |
| Famotidine | 49 | $546 | $11 |
| Spironolactone | 18 | $323 | $18 |
| Furosemide | 14 | $141 | $10 |
2020: 6 drugs
| Mesalamine | 17 | $6,201 | $365 |
| Gavilyte-C | 70 | $1,342 | $19 |
| Omeprazole | 37 | $533 | $14 |
| Famotidine | 38 | $401 | $11 |
| Peg-3350 and Electrolytes | 16 | $362 | $23 |
| Pantoprazole | 12 | $198 | $16 |
2019: 10 drugs
| Xifaxan | 21 | $41,850 | $1,993 |
| Lialda | 15 | $17,372 | $1,158 |
| Gavilyte-C | 158 | $5,593 | $35 |
| Mercaptopurine | 11 | $1,556 | $141 |
| Sucralfate | 12 | $1,531 | $128 |
| Omeprazole | 41 | $672 | $16 |
| Gavilyte-G | 15 | $363 | $24 |
| Pantoprazole | 19 | $363 | $19 |
| Famotidine | 22 | $320 | $15 |
| Prednisone | 14 | $285 | $20 |
2018: 9 drugs
| Lialda | 16 | $22,131 | $1,383 |
| Gavilyte-C | 105 | $3,803 | $36 |
| Peg 3350-Electrolyte | 81 | $2,931 | $36 |
| Moviprep | 20 | $1,836 | $92 |
| Famotidine | 29 | $682 | $24 |
| Omeprazole | 39 | $629 | $16 |
| Pantoprazole | 12 | $293 | $24 |
| Metronidazole | 13 | $123 | $9 |
| Ondansetron | 14 | $122 | $9 |
2017: 4 drugs
| Gavilyte-C | 184 | $3,140 | $17 |
| Moviprep | 11 | $926 | $84 |
| Omeprazole | 52 | $813 | $16 |
| Famotidine | 15 | $487 | $32 |
2016: 2 drugs
| Gavilyte-C | 33 | $561 | $17 |
| Omeprazole | 11 | $229 | $21 |
2014: 2 drugs
| Peg 3350-Electrolyte | 27 | $289 | $11 |
| Gavilyte-C | 15 | $176 | $12 |
2013: 1 drug
| Peg 3350-Electrolyte | 16 | $173 | $11 |
Professional record
- NPI
- 1831480466
- Licence
- CA A121409California A121409: Current · expires 2028-05-31
- Trained
- Meharry Medical College School of Medicine, 2010
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X); Student in a training program (390200000X)
- Mailing address
- 270 International Cir, San Jose, CA, 95119
- NPI first listed
- 2011-05-01
- NPI last updated
- 2022-02-11
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.